For compounded semaglutide specifically, treatment duration considerations are similar, but access and cost dynamics differ
Typically, such medications are kept refrigerated between 2C and 8C (36F to 46F) in their original packaging to protect them from light and contamination
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
Switching GLP-1 medications and how it affects your timeline Switching between GLP-1 medications is increasingly common as patients seek better results, fewer side effects, or respond to availability changes
You didnt start GLP-1 therapy to become a full-time meal-prep strategist
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management